Rheumatoid Arthritis and Cardiovascular Risk: A Comprehensive Patient Review

Published: 29 October 2026 18 min read Dr. Shimaa Sherif

Medically reviewed by: Dr. Mohab Ashraf Fouad

This article was translated into English from the Arabic original and reviewed for medical accuracy.

Article illustration: Rheumatoid Arthritis and Cardiovascular Risk: A Comprehensive Patient Review

Why Does Cardiovascular Health Matter in Rheumatoid Arthritis?

When managing rheumatoid arthritis, patients and clinicians naturally concentrate on relieving joint swelling, morning stiffness, and pain. However, rheumatoid arthritis is fundamentally a systemic autoimmune condition that is not confined to the joints alone; its chronic inflammatory activity can also influence the vascular system and heart [1, 7]. Broad observational studies and medical meta-analyses indicate that individuals with rheumatoid arthritis experience higher population-level rates of coronary artery conditions, heart attacks, and heart failure compared to individuals of similar age without inflammatory joint disease [7, 11]. Importantly, these statistical trends do not mean that heart complications are inevitable for every patient. Individual cardiovascular risk varies considerably based on how effectively inflammation is suppressed over time, genetic background, and routine vascular health factors like blood pressure, cholesterol, and daily lifestyle [1, 2].

The underlying link is persistent systemic inflammation circulating through the bloodstream over months and years. Long-term inflammatory signals can gradually affect the lining of blood vessels, promoting arterial stiffness and accelerating the buildup of fatty deposits in the arteries [1, 7]. Moreover, chronic inflammation interacts with common vascular factors such as physical inactivity or elevated blood pressure, amplifying their potential impact [2, 11]. For these reasons, modern rheumatology views cardiovascular protection not as an afterthought, but as an essential, proactive component of comprehensive, long-term patient care [1, 2].

EULAR Recommendations and Clinical Cardiovascular Risk Assessment

The European Alliance of Associations for Rheumatology (EULAR) established clinical recommendations to guide cardiovascular risk management in patients with rheumatoid arthritis [1]. A central principle of these recommendations is that the treating rheumatologist plays a key role in ensuring cardiovascular risk factors are regularly reviewed, working in close coordination with primary care and internal medicine physicians [1]. EULAR recommends that cardiovascular risk assessment be performed around the time of diagnosis and formally repeated at least once every five years, with re-evaluation considered after major changes in antirheumatic therapies [1]. Controlling arthritis activity rigorously—aiming for clinical remission or low disease activity—remains the foundation for lowering inflammatory stress on blood vessels [1, 6]. Consequently, discussing comprehensive treatment options and disease monitoring with your rheumatologist helps ensure systemic inflammation is kept under steady control [1].

Clinical studies demonstrate that standard cardiovascular risk calculators created for the general population often underestimate true risk in individuals with rheumatoid arthritis, as standard models do not capture chronic immune-mediated inflammation [1, 6]. In its 2015/2016 guideline update, EULAR recommended that clinicians adjust calculated cardiovascular risk upward for all patients with rheumatoid arthritis when using general risk engines that do not already incorporate inflammatory arthritis [1]. Crucially, this adjustment is an internal clinician calculation designed to avoid underestimating risk, rather than a formula for patients to calculate at home. Moreover, clinical validation studies show that mathematical models alone cannot replace thoughtful medical judgment; your physician combines score estimates with a comprehensive review of your disease duration, symptoms, and individual health profile to guide preventive decisions [1, 6].

Blood Pressure Screening and Kidney Health in Rheumatoid Arthritis

Hypertension is among the most frequent and manageable cardiovascular risk factors in people with rheumatoid arthritis, yet it often develops quietly without noticeable warning symptoms [10]. Several factors can contribute to elevated blood pressure in this setting, including long-term vascular changes related to chronic inflammation, reduced daily movement secondary to joint discomfort, and the effects of medications such as non-steroidal anti-inflammatory drugs and oral cortisone, which can promote fluid retention and alter blood pressure regulation [1, 10].

Cardiovascular and hypertension guidelines recommend checking resting blood pressure during routine outpatient visits using a properly fitted cuff [1, 10]. Patients are also encouraged to keep a home log of resting readings to provide their physician with realistic day-to-day data and distinguish sustained hypertension from temporary clinic anxiety [10]. Because kidney health is closely tied to blood pressure balance and can be influenced by medications, the physician may order kidney function tests or urine checks when clinically indicated—such as when blood pressure is persistently elevated or medications are adjusted—rather than requiring an exhaustive universal laboratory panel at every routine visit [1, 10]. Effective blood pressure control blends lifestyle adjustments—like moderating excess sodium and supporting healthy weight—with personalized medications selected to work safely alongside ongoing antirheumatic treatments [1, 10].

Lipid Screening and Understanding the Lipid Paradox

Interpreting lipid panels in rheumatoid arthritis requires careful clinical perspective. In the general population, higher levels of low-density lipoprotein (LDL) cholesterol clearly correlate with plaque buildup in the arteries. However, during periods of active, severe arthritis inflammation, clinical studies demonstrate that circulating total cholesterol and LDL readings on blood tests can appear deceptively lower [1, 5]. This phenomenon is widely recognized in rheumatology: lower laboratory cholesterol values during an active inflammatory flare do not mean the cardiovascular system is protected, and patients should not take false reassurance from lower readings measured when joints are flared [1, 5]. At the same time, this does not imply that low cholesterol is itself a direct toxin or cause of disease; rather, active inflammation alters normal lipid behavior while placing independent stress on the blood vessels [1, 5].

For this reason, cardiovascular and EULAR guidelines advise that lipid profiles are ideally evaluated when rheumatoid arthritis activity is stable or in remission, enabling the physician to observe the patient's representative baseline numbers [1, 4]. This does not translate into an automatic, mandatory recheck for every person the moment remission occurs; rather, your doctor times lipid screening sensibly as disease control stabilizes. Furthermore, clinical guidelines emphasize that statins or lipid-lowering therapies are not prescribed universally to everyone with rheumatoid arthritis solely because of the diagnosis. Instead, the decision to initiate statin therapy is tailored individually based on comprehensive cardiovascular risk estimation, baseline lipid thresholds, and established prevention guidelines [1, 4].

Blood Glucose, Metabolic Factors, and Cortisone Context

Metabolic health and insulin balance are closely intertwined with rheumatoid arthritis. Longstanding systemic inflammation can interfere with normal insulin response, increasing the likelihood of insulin resistance and elevating the long-term risk of developing type 2 diabetes [1, 2]. In addition, oral cortisone (glucocorticoid) therapy—especially when prescribed at moderate-to-high doses or taken over extended periods—can elevate blood glucose levels, placing added metabolic demand on the vascular system and highlighting the necessity of attentive metabolic oversight [1, 3].

Clinicians recommend monitoring fasting blood glucose and glycated hemoglobin (HbA1c) periodically, tailoring the frequency of checks to the individual patient. Individuals who require ongoing steroid treatment, those with central weight, or those with a personal or family history of metabolic concerns benefit from closer glucose evaluation [1, 2]. Identifying early shifts in blood sugar allows timely lifestyle and medical adjustments that safeguard blood vessels before sustained metabolic strain occurs. Alongside medical management, adopting supportive dietary patterns for rheumatoid arthritis plays an important role in metabolic resilience, emphasizing vegetables, olive oil, and fish to support cardiovascular and joint wellness [1, 3].

Smoking Cessation: Dual Protection for Heart and Joints

Tobacco smoking represents a major modifiable risk factor that concurrently undermines both joint health and cardiovascular safety in rheumatoid arthritis [1, 2]. From a joint perspective, smoking is consistently linked with higher disease activity, greater joint discomfort, and poorer responses to several antirheumatic therapies, making sustained inflammation harder to manage [1, 11].

From a cardiovascular perspective, cigarette smoke damages blood vessel walls, accelerates the development of arterial plaques, and elevates resting heart rate, substantially increasing the likelihood of heart attacks and strokes [2, 3]. Consequently, choosing to quit smoking delivers practical, dual benefits: it reduces ongoing strain on the heart and circulation while supporting better overall control of arthritis [1, 2]. Patients are encouraged to discuss cessation support with their treating physician, who can provide structured guidance and medically approved cessation aids tailored to their health needs [1, 3].

Joint-Safe Physical Activity and Heart Health

It is understandable that individuals living with rheumatoid arthritis may worry that physical activity will trigger joint pain, leading some to avoid exercise altogether. However, extended inactivity can result in cardiovascular deconditioning, reduced stamina, and weakening of the muscles that support and stabilize joints [9]. Dedicated physical activity recommendations from EULAR confirm that structured, appropriate physical activity is beneficial and practical for people with inflammatory arthritis, supporting functional independence and general physical conditioning [9].

Importantly, exercise intensity and type must be thoughtfully adapted to current disease activity and joint symptoms. During acute inflammatory flares when joints are warm or swollen, strenuous workouts should be scaled back, focusing on gentle range-of-motion movements and joint rest [9]. When arthritis activity is calm or controlled, low-impact aerobic activities—such as brisk walking on even paths, warm-water aquatic exercise, and stationary cycling—help condition the heart and improve vascular fitness without placing harsh impact forces on weight-bearing joints [1, 9]. Consulting your rheumatologist or physical therapist to select joint-friendly exercises for arthritis ensures you build muscle strength progressively and safely [9].

Antirheumatic Medications and Cardiovascular Balance

Medications prescribed for rheumatoid arthritis exert significant effects on overall health, requiring an evidence-based clinical balance between suppressing joint inflammation and supporting cardiovascular safety [1, 8]. Observational registry analyses and large cohort reviews note that patients receiving conventional disease-modifying therapies (such as methotrexate) or targeted biologics frequently experience lower rates of cardiovascular events compared to individuals with untreated, persistent inflammation [1, 8]. However, observational registry associations do not prove a direct causal protective effect across all clinical settings, and taking arthritis medications does not replace diligent attention to blood pressure, lipids, and daily health habits [1, 8].

Conversely, certain medications involve cardiovascular considerations: non-steroidal anti-inflammatory drugs and oral corticosteroids can influence blood pressure, fluid balance, and renal hemodynamics [1, 8]. The treating physician evaluates the cardiovascular tradeoffs of anti-inflammatory medications and steroids, tailoring dosages to the patient's individual condition and tapering steroids when joint control allows [1, 8]. Importantly, patients must never stop, taper, or modify their prescribed antirheumatic medications or steroids on their own, as abrupt discontinuation can trigger disease flares that place renewed stress on the vascular system. Understanding clinical guidance on methotrexate safety and lab monitoring helps patients and their clinicians ensure treatment remains safe and effective over the long term [8].

Warning Signs, Emergencies, and Coordinated Care at La Rose Clinics

Patients with rheumatoid arthritis may sometimes experience chest wall discomfort caused by inflammation of the costochondral joints or muscular soreness, but chest discomfort can have several causes, and symptoms alone cannot safely distinguish musculoskeletal from cardiac causes [1, 11]. However, recognizing cardiac emergency warning signs is critically important so that immediate medical action can be taken without delay. Any sensation of heavy pressure, tightness, squeezing, or crushing discomfort in the center of the chest, pain radiating to the left arm, shoulder, neck, jaw, or back, sudden shortness of breath, lightheadedness, or unexplained cold sweats represents a medical emergency [7, 11, 12]. These warning signs must never be dismissed as routine arthritis symptoms or musculoskeletal discomfort; immediate emergency medical evaluation is essential [2, 11].

For ongoing, non-emergency care, an attentive approach addresses both joint stability and overall cardiovascular wellness. Rheumatology consultations are offered at La Rose Clinics across our Maadi and Fifth Settlement branches, where rheumatologists monitor disease activity, optimize medical therapy, and assess routine cardiovascular risk factors. In addition, internal medicine care is available at our Maadi branch to assist with managing concurrent conditions like hypertension and diabetes. When clinical symptoms or screening results indicate the need for specialized cardiac assessment, your physician can advise an outside cardiology evaluation. If you are living with rheumatoid arthritis and seeking personalized care that addresses joint health and general cardiovascular risk assessment, booking an in-person consultation at La Rose Clinics provides you with attentive clinical evaluation and ongoing support.

Medical sources

  1. Agca R et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017 Jan;76(1):17-28.
  2. Visseren FLJ et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337.
  3. Arnett DK et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646.
  4. Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188.
  5. Myasoedova E et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011 Mar;70(3):482-7.
  6. Crowson CS et al. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110.
  7. Avina-Zubieta JA et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524-9.
  8. Roubille C et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015 Mar;74(3):480-9.
  9. Rausch Osthoff AK et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018 Sep;77(9):1251-1260.
  10. Unger T et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. J Hypertens. 2020 Jun;38(6):982-1004.
  11. NHS - Rheumatoid arthritis: Complications. National Health Service UK.
  12. NHS - Heart attack. National Health Service UK.

Knowledge Centre

How this article was reviewed

This content is for health education and does not replace diagnosis or an individual care plan.

Medically reviewed by
Dr. Mohab Ashraf Fouad
Linked medical sources
12
Publication and review history
  1. Published: 29 October 2026
  2. Last updated: 30 October 2026
  3. Review record: Medical review recorded
  4. Linked medical sources: 12

Frequently asked questions

No, absolutely not. Population-level epidemiological studies show an increased statistical risk among groups of patients with rheumatoid arthritis, but population statistics do not dictate what will happen to any individual [1, 7]. Many people with rheumatoid arthritis live long, healthy lives without ever developing heart problems, especially when systemic inflammation is controlled early, smoking is avoided, and vascular risk factors such as blood pressure and cholesterol are managed proactively [1, 6]. The purpose of understanding this connection is not to cause worry, but to guide practical, personalized prevention [1].

The lipid paradox describes a recognized clinical observation in which active, intense arthritis inflammation temporarily lowers circulating total and LDL cholesterol readings on standard blood tests [1, 5]. Even though the laboratory numbers may appear lower or normal, this does not mean the blood vessels are protected, and patients should not take false reassurance from lower readings during a flare; active inflammation independently places strain on the arteries [1, 5]. For this reason, guidelines advise that lipid levels are best evaluated once disease activity is stable, allowing your doctor to observe your true lipid baseline and determine whether preventive treatment is indicated [1, 4].

No. Clinical guidelines advise against routine, universal prescription of daily aspirin or statins solely because a person has rheumatoid arthritis [1, 2]. The decision to initiate statin therapy is individualized, based on overall cardiovascular risk assessment, baseline lipid levels, and established prevention guidelines [3, 4]. Similarly, daily aspirin for primary prevention is not universally recommended in the absence of established heart disease due to potential gastrointestinal bleeding risks, especially when taken alongside anti-inflammatory medications; any decision regarding preventive pharmacotherapy must be customized by the treating physician [1, 2].

EULAR guidelines recommend that a comprehensive cardiovascular risk assessment be conducted around the time of initial diagnosis and repeated formally at least once every five years [1, 10]. A re-evaluation should also be considered after major changes in antirheumatic therapies [1]. Resting blood pressure is checked during routine clinical visits [10]. Other laboratory evaluations, such as blood glucose, kidney function, or lipid tests, are scheduled by the physician based on individual health findings, medication regimens, and personal risk factors rather than a rigid universal testing battery at every visit [1, 2].

Musculoskeletal chest wall discomfort—such as costochondritis—is usually superficial, tender to direct touch over the rib joints, and worsens with deep breathing, coughing, or twisting the torso [1, 11]. In contrast, cardiac ischemia classically feels like deep, retrosternal pressure, heaviness, tightness, or squeezing that is not changed by pressing on the chest [7, 11]. It often radiates to the left arm, shoulder, neck, jaw, or back, and may be accompanied by sudden breathlessness, cold sweating, or dizziness [7, 11]. If there is any uncertainty, seek emergency medical care immediately [2, 11].

Low-impact aerobic exercises are ideal because they condition the cardiovascular system and improve stamina without subjecting vulnerable joints to heavy impact stresses [1, 9]. Excellent modalities include brisk walking on level surfaces, warm-water aquatic exercise, swimming, and stationary bicycling [9]. Gentle resistance and flexibility exercises also help strengthen supporting muscles around joints and relieve stiffness [9]. Exercise intensity should always be adapted to how your joints feel; activities should be eased during active flares, and a progressive routine can be guided by your physician or physical therapist [9].

Written by

Dr. Shimaa Sherif

Specialist in Rheumatology, Joint Diseases, Physical Medicine and Rehabilitation

Dr. Shimaa Sherif is a specialist in rheumatology, joint diseases, physical medicine and rehabilitation, with an MSc in Rheumatology and Rehabilitation and extensive experience in diagnosing and treating…

View profile

Medically reviewed by

Dr. Mohab Ashraf Fouad

Specialist in Internal Medicine & Diabetes, Hepatology, Gastroenterology & Endoscopy

Dr. Mohab Ashraf Fouad is a specialist in internal medicine and diabetes, and in hepatology, gastroenterology and endoscopy, with an MSc in General Internal Medicine, Hepatology, Gastroenterology and Endoscopy…

View profile

You may also find helpful

Start with a real consultation - book now

Booking ahead is required. Patients are seen in order of arrival.